Prevalence and Consequences of Hyperlactemia Following Pancreatic Surgery

The goal of this observational study is to investigate the role of lactate elevation.

The main aims are:

* Determine the frequency of lactate elevation following pancreatic surgery and its relationship to postoperative complications * Investigate what patient and surgical related factors that are associated with postoperative lactate elevation This is a retrospective study based on existing medical data and will not affect the medical care of the studied patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatic Cancer Chronic Disease Chronic Pancreatitis Cysts Digestive System Diseases Digestive System Neoplasms Disease Attributes Endocrine Gland Neoplasms Endocrine System Diseases Neoplasms Neoplasms by Site Pancreatic Cyst Pancreatic Diseases Pancreatic Neoplasms Pancreatitis Pancreatitis, Chronic Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Karolinska University Hospital

Huddinge, Stockholm County, 141 86, Sweden

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing pancreatic surgery 2016-2018

Exclusion criteria

Patients unable to undergo scheduled surgery
Missing data in the postoperative period

Treatment and study plan

Primary outcomes

Length of hospital stay

Time frame: All patients are followed until they leave the hospital, but a maximum of six months

hospital stay following surgery

Secondary outcomes

General postoperative complications

Time frame: All patients are followed until they leave the hospital, but a maximum of six months

Defined as Clavien-Dindo grade III-V
ICU care

Time frame: All patients are followed until they leave the hospital, but a maximum of six months

Organ failure requiring ICU care
Surgery specific complications

Time frame: 90 days

Pancreatic fistula, bile leakage, delayed gastric emptying

Sponsors and collaborators

Lead sponsor

Karolinska University Hospital

Other

Registry information

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Sep 19, 2024
Registry last updated: Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed